Endogenex vs Inversago Pharma
Endogenex
Treating the gut may redefine what's possible in diabetes care
27 employees · est. 2017 · Plymouth, United States
Inversago Pharma
Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrotic conditions
est. 2015
Inversago Pharma is the older company (2017 vs 2015).
Side-by-Side Comparison
| Metric | Endogenex | Inversago Pharma |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2015 older |
| Headquarters | ||
| Headquarters | Plymouth, United States | Not tracked yet |
| Employees | ||
| Employees | 27 | Not tracked yet |
| Industry | ||
| Industry | Health Care, Health and Wellness, Medical Devices | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series C | Series C |
| Total Funding | ||
| Total Funding | $113.00M | $137.00M |
| Funding Rounds | ||
| Funding Rounds | 6 | 3 |
| Services | ||
| Services | Development of Endogenex System, Clinical Evaluation and Studies, Diabetes Therapeutic Research | Not tracked yet |
| Target Customers | ||
| Target Customers | Diabetes Patients, Healthcare Providers, Clinical Researchers, Medical Institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Type 2 Diabetes TreatmentMetabolic SignalingRegenerative MedicinePulsed Electric FieldsDuodenal Mucosa RegenerationGlycemic Control +8 | Biotech CompanyClinical-stageTherapiesMetabolic ConditionsFibrotic ConditionsCB1 Blockade +9 |
| Website | ||
| Website | endogenex.com | inversago.com |
About Endogenex
Endogenex, a Minneapolis-based company founded in 2017, is poised to transform diabetes care through pioneering medical innovations. With its strong partnership with the Mayo Clinic, the company is leveraging advanced technology to treat Type 2 Diabetes (T2D) by resetting the body's metabolic signal...
About Inversago Pharma
Inversago Pharma is a Montreal-based biotech company, founded in 2015, that focuses on developing innovative therapies for patients with metabolic and fibrotic conditions. Specializing in CB1 blockade through peripherally-acting, CB1 inverse agonists, the company aims to enhance treatment options fo...
Also comparing in this category
Comparing more than these two?
Get Endogenex, Inversago Pharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Endogenex compare?
A PDF of Endogenex and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Endogenex with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Endogenex on 20 Mar 2026, and Inversago Pharma on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
